Miracle Mile Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Buy
7,953
+537
+7% +$149K 0.02% 348
2026
Q1
$2.19M Buy
7,416
+210
+3% +$62.4K 0.03% 293
2025
Q4
$1.97M Buy
7,206
+592
+9% +$161K 0.03% 300
2025
Q3
$1.79M Buy
6,614
+992
+18% +$270K 0.03% 313
2025
Q2
$1.55M Buy
5,622
+745
+15% +$203K 0.03% 287
2025
Q1
$1.29M Buy
4,877
+353
+8% +$87.1K 0.03% 286
2024
Q4
$1.05M Buy
4,524
+687
+18% +$158K 0.02% 329
2024
Q3
$847K Buy
3,837
+609
+19% +$126K 0.02% 297
2024
Q2
$635K Sell
3,228
-348
-10% -$71.9K 0.02% 322
2024
Q1
$770K Buy
3,576
+368
+11% +$77.3K 0.02% 294
2023
Q4
$676K Buy
+3,208
New +$684K 0.02% 306
2020
Q2
Sell
-3,233
Closed -$559K 310
2020
Q1
$559K Buy
+3,233
New +$643K 0.06% 174

Other funds holding CME

Miracle Mile Advisors's CME Position: Q2 2026 in Review

Miracle Mile Advisors increased its CME Group (CME) stake by 7.2% in Q2 2026, buying an estimated $149K and bringing the position to 7,953 shares worth $1.76M. The position accounts for 0.02% of the portfolio, ranked #348.

Miracle Mile Advisors first reported a position in CME in Q1 2020 and has held it in 12 quarters since. The position peaked at $2.19M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Miracle Mile Advisors held 7,953 shares of CME Group worth $1.76M as of Q2 2026.
  • Miracle Mile Advisors bought 537 CME Group shares in Q2 2026, an estimated $149K.
  • CME Group made up 0.02% of Miracle Mile Advisors's portfolio in Q2 2026, its #348 holding.
  • Miracle Mile Advisors first reported a position in CME Group in Q1 2020 and has held it in 12 quarters since.
  • Miracle Mile Advisors's CME Group position peaked at $2.19M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.